Axogen (AXGN) Other Working Capital Changes (2010 - 2026)
Axogen's (AXGN) quarterly Other Working Capital Changes came in at -$559000.0 in Q1 2026, down 23.67% year-on-year from -$732371.0 in Q1 2025, and up 49.37% quarter-over-quarter from -$1.1 million in Q4 2025.
Axogen (AXGN) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Axogen's Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$559000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 23.67% year-over-year to -$559000.0 in Q1 2026; TTM through Mar 2026 was -$2.0 million, a 20.59% decrease from a year earlier, with the FY2025 full-year figure at -$1.9 million, down 20.84% from the prior year.
- Other Working Capital Changes improved to -$559000.0 in Q1 2026 per AXGN's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.3 million in Q4 2025 and bottomed at -$1.2 million in Q2 2024.
- The 5-year median for Other Working Capital Changes is $244000.0 (2023), against an average of $261176.5.
- Across the five-year window, Other Working Capital Changes slumped 31900.0% in 2022 and jumped 75.74% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at $856000.0 in 2022, then slumped by 130.02% to -$257000.0 in 2023, then fell by 16.73% to -$300000.0 in 2024, then slumped by 268.0% to -$1.1 million in 2025, then soared by 49.37% to -$559000.0 in 2026.
- Per Business Quant, the three latest AXGN Other Working Capital Changes figures stand at -$559000.0 (Q1 2026), -$1.1 million (Q4 2025), and -$291000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 368,000.00 |
| Mar 31, 2026 | 368,000.00 |
| Mar 31, 2026 | 368,000.00 |
| Dec 31, 2025 | 3.29 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | 538,000.00 |
| Sep 30, 2025 | 538,000.00 |
| Sep 30, 2025 | 538,000.00 |
| Jun 30, 2025 | -408,000.00 |
| Jun 30, 2025 | -408,000.00 |
| Jun 30, 2025 | -408,000.00 |
| Mar 31, 2025 | 489,000.00 |
| Mar 31, 2025 | 489,000.00 |
| Mar 31, 2025 | 489,000.00 |
| Dec 31, 2024 | 405,000.00 |
| Dec 31, 2024 | 405,000.00 |
| Dec 31, 2024 | 405,000.00 |
| Sep 30, 2024 | -232,000.00 |
| Sep 30, 2024 | -232,000.00 |